U.S. Markets close in 12 mins
  • S&P 500

    3,901.78
    -21.90 (-0.56%)
     
  • Dow 30

    31,252.37
    -237.70 (-0.75%)
     
  • Nasdaq

    11,400.79
    -17.36 (-0.15%)
     
  • Russell 2000

    1,780.79
    +5.94 (+0.33%)
     
  • Crude Oil

    111.62
    +2.03 (+1.85%)
     
  • Gold

    1,839.40
    +23.50 (+1.29%)
     
  • Silver

    21.93
    +0.39 (+1.79%)
     
  • EUR/USD

    1.0590
    +0.0124 (+1.1861%)
     
  • 10-Yr Bond

    2.8550
    -0.0310 (-1.07%)
     
  • Vix

    29.86
    -1.10 (-3.55%)
     
  • GBP/USD

    1.2493
    +0.0150 (+1.2180%)
     
  • USD/JPY

    127.6900
    -0.6070 (-0.4731%)
     
  • BTC-USD

    30,006.29
    +727.13 (+2.48%)
     
  • CMC Crypto 200

    667.16
    +14.93 (+2.29%)
     
  • FTSE 100

    7,302.74
    -135.35 (-1.82%)
     
  • Nikkei 225

    26,402.84
    -508.36 (-1.89%)
     

Judge rules for Fresenius in bid to end $4.8 bln Akorn deal

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

WILMINGTON, Del, Oct 1 (Reuters) - A Delaware judge ruled on Monday that German healthcare group Fresenius SE could walk away from its $4.75 billion deal for U.S. drugmaker Akorn Inc and rejected Akorn's claim that the merger agreement had been breached.

Delaware Vice Chancellor Travis Laster said Fresenius validly terminated the merger agreement and he found Akorn's representations regarding its compliance with regulatory requirements were "not true and correct." (Reporting by Tom Hals in Wilmington, Delaware)